Table 7.
Diagnostic accuracy of CBCfor COVID-19: sensitivity, specificity, positive predictive value, and negativepredictive value.
|
| Variable |
Case Positive |
Case Negative |
Control Positive |
Control Negative |
Sensitivity |
Specificity |
PVP |
PVN |
|
|
| Leucopenia |
21 (24.1%) |
66 (75.9%) |
4 (4.7%) |
82 (95.3%) |
24.1% |
95.3% |
84% |
55% |
|
| Neutropenia |
12 (13.8%) |
75 (86.2%) |
5 (5.8%) |
81 (94.2%) |
13% |
94% |
70.5%, |
49.7% |
|
| Lymphopenia |
53 (60.9%) |
34 (39.1%) |
21 (24.4%) |
65 (75.6%) |
60.9% |
75.6% |
71.6% |
65.6% |
|
| Eosinocytopenia |
35 (40.2%) |
52 (59.8%) |
25 (29.1%) |
61 (70.9%) |
40.2% |
70.9%, |
58.3%, |
53.9% |
|
| Monocytosis |
2 (2.3%) |
85 (97.7%) |
14 (16.3%) |
72 (83.7%) |
2.3% |
83.7%, |
12.5% |
45.8% |
|
|
|
